Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

International Journal of Cancer

Volumn 85, Issue 1, 2000, Pages 35-39

  Koskela, Pentti ^a   Anttila, Tarja ^a   Bjørge, Tone ^b   Brunsvig, Anne ^c   Dillner, Joakim ^d   Hakama, Matti ^e   Hakulinen, Timo ^f   Jellum, Egil ^c   Lehtinen, Matti ^a   Lenner, Per ^g   Luostarinen, Tapio ^h   Pukkala, Eero ^h   Saikku, Pekka ⁱ   Thoresen, Steinar ^b   Youngman, Linda ^j   Paavonen, Jorma ^f  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b INSTITUTE OF CANCER RESEARCH   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF TAMPERE   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^h FINNISH CANCER REGISTRY   (Finland)

ⁱ UNIVERSITY OF OULU   (Finland)

^j UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; SEXUAL BEHAVIOR; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ANTIBODIES, BACTERIAL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; FEMALE; FINLAND; HUMANS; NEOPLASM INVASIVENESS; NORWAY; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SMOKING; SWEDEN; UTERINE CERVICAL NEOPLASMS;

EID: 0033991673     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A     Document Type: Article

References (24)

1. AF GEIJERSSTAM, V., KIBUR, M., WANG, Z., KOSKELA, P.. PUKKALA, E., SCHILLER, J., LEHTINEN, M. and DILLNER, J., Stability over time of serum antibody levels to human papillomavirus type 16. J. infect. Dis., 177, 1710-1714 (1998).
2. BJØRGE, T. and 13 OTHERS, Prospective, seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. Brit. med. J., 315, 646-649 (1997),
3. BOSCH, E.X., CASTELLSAOUE, X., MUÑOZ, N., DE SANJOSÉ, S., GHAFFARI, A.M., GONZÁLES, M.G., IZARZUGAZA, P.V., NAVARRO, C., VERGARA, A., ASCUNTE, N., GUERRERO, E. and SHAH, K.V., Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J. nat. Cancer Inst., 88, 1060-1067 (1996).
4. DILLNER, J., KALLINGS, I., BRIHMER, C., SIKSTRÖM, B., KOSKELA, P., LEHTINEN, M., SCHILLER, J.T., SAPP, M. and MÅRDH, P.A., Seropositivity to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behaviour. J. infect. Dis., 173, 1394-1398 (1996).
5. DILLNER, J. and 14 OTHERS, Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J. nat. Cancer Inst., 89, 1293-1299 (1997).
6. DOLL, R. and PETO, R., The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. nat. Cancer Inst., 66, 1191-1308 (1981).
7. HAKAMA, M., LEHTINEN, M., KNEKT, P., AROMAA, A., LEINIKKI, P., MIETTINEN, A., PAAVONEN, P., PETO. R. and TEPPO, L., Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Amer. J. Epidemiol., 137, 166-170 (1993).
8. HAKAMA, M., MAGNUS, K., PETTERSSON, F., STORM, H. and TULINIUS, H., Effect of organized screening on the risk of cervical cancer in the Nordic Countries. In: A.B. Miller, J. Chamberlain, N.E. Day, M. Hakama and P.C. Prorok (eds.), UICC project on evaluation of screening for cancer, pp. 153-162. Cambridge University Press. Cambridge (1991).
9. IARC, Human papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans. IARC Scientific Publication 64, IARC, Lyon (1995).
10. JELLUM, E., ANDERSEN, A., LUND-LARSEN, P., THEODORSEN, L. and ØRJASÆTER, H., Experiences of the Janus Serum Bank in Norway. Environ. Hlth Perspect., 103 (Suppl. 3), 85-88 (1995).
11. LAURJLA, A., ANTTILA, T., LÄÄRÄ, E., BLOIGU, A.. VIRTAMO, J., ALBANES, D., LEINONEN, M. and SAIKKU, P., Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int. J. Cancer, 74, 31-34 (1997).
12. LEHTINEN, M., DILLNER, J., KNEKT, P., LUOSTARINEN, T., AROMAA, A., KIRNBAUER, R., KOSKELA, P., PAAVONEN, J., PETO, R., SCHILLER, J.T. and HAKAMA. M., Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. Brit. med. J., 312, 537-539 (1996).
13. MEHTA, C.P., PATEL, N.R. and GRAY, R., Computing an exact confidence interval for the common odds ratio in several 2 × 2 contingency tables. J. Amer. Statist. Ass., 80, 969-973 (1985).
14. PAAVONEN, J., STEVENS, C.E., WÖLNER-HANSSEN, P., CRITCHLOW, C.W., DEROUEN, T., KIVIAT, N., KOUTSKY, L., STAMM, W.E., COREY, L. and HOLMES, K.K., Colposcopic manifestations of cervical and vaginal infections. Obstet. Gynecol. Surv., 43, 373-381 (1988).
15. PARISH, S., COLLINS, R., PETO, R., YOUNGMAN, L., BARTON, J., JAYNE, K., CLARKE, R., APPLEBY, P., LYON, V., CEDERHOLM-WILLIAMS, S., MARSHALL, J. and SLEIGHT, P., Cigarette smoking, tar yields and non-fatal myocardial infarction: 14000 cases and 32000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. Brit. med. J., 311, 471-477 (1995).
16. PISANI, P., PARKIN, D.M. and FERLAY, J., Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int. J. Cancer, 55, 891-903 (1993).
17. PUOLAKKAINEN, M., VESTERINEN, E., PUROLA, E., SAIKKU, P. and PAAVONEN, J., Persistence of chlamydial antibodies after pelvic inflammatory disease. J. clin. Microbiol., 23, 924-928 (1986).
18. ROTKIN, I.D., A comparison of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res., 33, 1353-1367 (1973).
19. SAIKKU, P. and WANG, S.-P., Chlamydia trachomatis immunotypes in Finland. Acta path. microbiol. immunol. scand. Sect. B., 95, 131-134 (1987).
20. SCHACHTER, J., HILL, B.C., KING, E.B., HEILBRON, D.C., RAY, R.M., MARGOLIS, A.J. and GREENWOOD, S.A., Chlamydia trachomatis and cervical neoplasia. J. Amer. med. Ass., 248, 2134-2138 (1982).
21. SCHEIMAN, J.M. and CUTLER, A.F., Helicobacter pylori and gastric cancer. Amer. J. Med., 106, 222-226 (1999).
22. SCHLOTT, T., RUDA, G., HOPPERT, M., NAGEL, H., REIMER, S., SCHUMACHER-LÜTGE, I.K. and DROESE, M., The in situ polymerase chain reaction for detection of Chlamydia trachomatis. J. Histochem. Cytochem., 46, 1017-1023 (1998).
23. WANG, S.-P. and GRAYSTON, J.T., Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect-immunofluorescence test. Amer. J. Ophthalmol., 70, 367-374 (1970).
24. WINKELSTEIN, W. JR, Smoking and cervical cancer-current status: a review. Amer. J. Epidemiol., 131, 945-957 (1990).